ATP6V0C

Chr 16AD

ATPase H+ transporting V0 subunit c

Also known as: ATP6C, ATP6L, ATPL, EPEO3, VATL, VPPC, Vma3

This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c", and d. This gene encodes the V0 subunit c. Alternative splicing results in transcript variants. Pseudogenes have been identified on chromosomes 6 and 17. [provided by RefSeq, Nov 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.671 OMIM phenotype
Clinical SummaryATP6V0C
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.74) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
20 unique Pathogenic / Likely Pathogenic· 30 VUS of 56 total submissions
📖
GeneReview available — ATP6V0C
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.67LOEUF
pLI 0.742
Z-score 1.96
OE 0.00 (0.000.67)
Moderately constrained

Typical tolerance to LoF variation

Missense Constraint?
2.99Z-score
OE missense 0.19 (0.140.28)
21 obs / 108.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.67)
00.351.4
Missense OE?0.19 (0.140.28)
00.61.4
Synonymous OE?1.17
01.21.6
LoF obs/exp: 0 / 4.5Missense obs/exp: 21 / 108.5Syn Z: -0.99
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongATP6V0C-related developmental disorderLOFAD

This gene — mechanism propensity

DN
0.7325th %ile
GOF
0.6833th %ile
LOF
0.3452th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

56 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic10
VUS30
Likely Benign2
Conflicting1
10
Pathogenic
10
Likely Pathogenic
30
VUS
2
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
6
0
0
10
Likely Pathogenic
3
7
0
0
10
VUS
4
24
2
0
30
Likely Benign
0
0
0
2
2
Benign
0
0
0
0
0
Conflicting
1
Total11372253

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

32 pathogenic / likely-pathogenic (of 47) ClinVar copy-number / structural variants overlap ATP6V0C — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ATP6V0C · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →